RNS System NAUTILUS Study | MicrobiomeTrials← Back to trialsNCT05147571
RNS System NAUTILUS Study
CompletedNAINTERVENTIONAL
Trial Details
Start: 2022-08-09Est. Completion: 2025-04-04
Enrollment target: 100 participants Locations- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Mayo Clinic - Arizona, Phoenix, Arizona, United States
- University of Colorado, Aurora, Colorado, United States
- Nicklaus Children's Hospital, Miami, Florida, United States
- University of South Florida, Tampa, Florida, United States
- Indiana University Health, Indianapolis, Indiana, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- University of Louisville, Louisville, Kentucky, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Spectrum Health Butterworth Hospital, Grand Rapids, Michigan, United States
- Mayo Clinic - Rochester, Rochester, Minnesota, United States
- Washington University, St Louis, Missouri, United States
- Mary Hitchcock Memorial Hospital (Dartmouth), Lebanon, New Hampshire, United States
- University of New Mexico, Albuquerque, New Mexico, United States
- New York University Langone, New York, New York, United States
- Oregon Health and Science University, Portland, Oregon, United States
Other microbiome trials you might be interested in
Drug Resistant Epilepsy
The purpose of this study is to assess the safety and performance of the iVEAcare Neuromodulation System for the treatme…
Multiple LocationsEst. completion Jun 2027
Rett Syndrome
Rett syndrome (RTT) is a rare genetic neurodevelopmental disorder caused primarily by mutations in the MECP2 gene, leadi…
Fortaleza, BrazilCompleted Jun 2027
University of Pennsylvania, Philadelphia, Pennsylvania, United StatesThomas Jefferson University, Philadelphia, Pennsylvania, United StatesUPMC, Pittsburgh, Pennsylvania, United StatesVanderbilt University Medical Center, Nashville, Tennessee, United StatesBaylor College of Medicine, Houston, Texas, United StatesThe University of Texas Health Science Center at Houston, Houston, Texas, United StatesUniversity of Utah Healthcare, Salt Lake City, Utah, United StatesRecruiting
ENDEAVOR is a Phase 1/2, 2-part, multicenter study to evaluate the safety and efficacy of ETX101 in participants with SC…
San Francisco, United StatesEst. completion Jan 2028